Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rutgers

Showing results (811-820 of 982) with videos related to

Pageof 99
Sort By:
Journal of the American Geriatrics Society|March 22, 2024
The link between the early surgery-induced inflammatory response and postoperative cognitive dysfunction in older patientsBaukje Brattinga, Matthijs Plas, Jacoba M Spikman, et al.
Breast Cancer Research and Treatment|September 23, 2020
Risk of heart failure after systemic treatment for early breast cancer: results of a cohort studyJudy N Jacobse, Michael Schaapveld, Naomi B Boekel, et al.
The American Journal of Surgical Pathology|February 28, 2015
Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significanceAndres A Roma, Andrea Diaz De Vivar, Kay J Park, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2011
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phaseEmiel Rutgers, Martine J Piccart-Gebhart, Jan Bogaerts, et al.
NPJ Breast Cancer|November 3, 2024
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancersFlorentine S Hilbers, Coralie Poncet, Konstantinos Tryfonidis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2012
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapyB B Koolen, M J T F D Vrancken Peeters, J Wesseling, et al.
Annales Chirurgiae Et Gynaecologiae|May 23, 1998
European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working GroupN O'Higgins, D A Linos, M Blichert-Toft, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 27, 2017
Additional value of <sup>18</sup>F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancerMette S van Ramshorst, Suzana C Teixeira, Bas B Koolen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2014
Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapyKenneth E Pengel, Bas B Koolen, Claudette E Loo, et al.
Breast Cancer Research and Treatment|March 9, 2023
De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES studyAnnemiek K E van Hemert, Josefien P van Olmen, Liesbeth J Boersma, et al.
Pageof 99

Showing results (811-820 of 982) with videos related to

Sort By:
Pageof 99
Journal of the American Geriatrics Society|March 22, 2024
The link between the early surgery-induced inflammatory response and postoperative cognitive dysfunction in older patientsBaukje Brattinga, Matthijs Plas, Jacoba M Spikman, et al.
Breast Cancer Research and Treatment|September 23, 2020
Risk of heart failure after systemic treatment for early breast cancer: results of a cohort studyJudy N Jacobse, Michael Schaapveld, Naomi B Boekel, et al.
The American Journal of Surgical Pathology|February 28, 2015
Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significanceAndres A Roma, Andrea Diaz De Vivar, Kay J Park, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2011
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phaseEmiel Rutgers, Martine J Piccart-Gebhart, Jan Bogaerts, et al.
NPJ Breast Cancer|November 3, 2024
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancersFlorentine S Hilbers, Coralie Poncet, Konstantinos Tryfonidis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2012
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapyB B Koolen, M J T F D Vrancken Peeters, J Wesseling, et al.
Annales Chirurgiae Et Gynaecologiae|May 23, 1998
European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working GroupN O'Higgins, D A Linos, M Blichert-Toft, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 27, 2017
Additional value of <sup>18</sup>F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancerMette S van Ramshorst, Suzana C Teixeira, Bas B Koolen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2014
Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapyKenneth E Pengel, Bas B Koolen, Claudette E Loo, et al.
Breast Cancer Research and Treatment|March 9, 2023
De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES studyAnnemiek K E van Hemert, Josefien P van Olmen, Liesbeth J Boersma, et al.
Pageof 99